These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 36172851)

  • 1. Targeted metabolomics combined with network pharmacology to reveal the protective role of luteolin in pulmonary arterial hypertension.
    Song K; Duan Q; Ren J; Yi J; Yu H; Che H; Yang C; Wang X; Li Q
    Food Funct; 2022 Oct; 13(20):10695-10709. PubMed ID: 36172851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of arachidonic acid metabolites on the control of non-differentiated intestinal epithelial cell growth.
    Cabral M; Martín-Venegas R; Moreno JJ
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1620-8. PubMed ID: 23685077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of oxidative stress caused by iron overload on arachidonic acid metabolites in MES23.5 cells.
    Chen L; Zhao Q; DU X; Chen XI; Jiao Q; Jiang H
    J Biosci; 2022; 47():. PubMed ID: 36550694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo release of 15-HETE and other arachidonic acid metabolites in nasal secretions during early allergic reactions.
    Ramis I; Catafau JR; Serra J; Bulbena O; Picado C; Gelpi E
    Prostaglandins; 1991 Nov; 42(5):411-20. PubMed ID: 1662405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of 15-lipoxygenase/15-hydroxyeicosatetraenoic acid in hypoxic pulmonary arterial hypertension].
    Yu H; Ma C; Zhu DL
    Sheng Li Xue Bao; 2021 Aug; 73(4):646-656. PubMed ID: 34405220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Celastramycin as a Novel Therapeutic Agent for Pulmonary Arterial Hypertension.
    Kurosawa R; Satoh K; Kikuchi N; Kikuchi H; Saigusa D; Al-Mamun ME; Siddique MAH; Omura J; Satoh T; Sunamura S; Nogi M; Numano K; Miyata S; Uruno A; Kano K; Matsumoto Y; Doi T; Aoki J; Oshima Y; Yamamoto M; Shimokawa H
    Circ Res; 2019 Jul; 125(3):309-327. PubMed ID: 31195886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabidiol attenuates pulmonary arterial hypertension by improving vascular smooth muscle cells mitochondrial function.
    Lu X; Zhang J; Liu H; Ma W; Yu L; Tan X; Wang S; Ren F; Li X; Li X
    Theranostics; 2021; 11(11):5267-5278. PubMed ID: 33859746
    [No Abstract]   [Full Text] [Related]  

  • 8. Aberrant arachidonic acid metabolism in esophageal adenocarcinogenesis, and the effects of sulindac, nordihydroguaiaretic acid, and alpha-difluoromethylornithine on tumorigenesis in a rat surgical model.
    Chen X; Li N; Wang S; Hong J; Fang M; Yousselfson J; Yang P; Newman RA; Lubet RA; Yang CS
    Carcinogenesis; 2002 Dec; 23(12):2095-102. PubMed ID: 12507933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of Pulmonary Vascular Remodeling in Hypoxia: Role of 15-LOX-2/15-HETE-MAPKs Pathway.
    Yu X; Li T; Liu X; Yu H; Hao Z; Chen Y; Zhang C; Liu Y; Li Q; Mao M; Zhu D
    Cell Physiol Biochem; 2015; 35(6):2079-97. PubMed ID: 25895668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effects of dioscin on vascular remodeling in pulmonary arterial hypertension via adjusting GRB2/ERK/PI3K-AKT signal.
    Yang Y; Yin L; Zhu M; Song S; Sun C; Han X; Xu Y; Zhao Y; Qi Y; Xu L; Peng JY
    Biomed Pharmacother; 2021 Jan; 133():111056. PubMed ID: 33378960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioactive Compounds From Coptidis Rhizoma Alleviate Pulmonary Arterial Hypertension by Inhibiting Pulmonary Artery Smooth Muscle Cells' Proliferation and Migration.
    Luo S; Kan J; Zhang J; Ye P; Wang D; Jiang X; Li M; Zhu L; Gu Y
    J Cardiovasc Pharmacol; 2021 Aug; 78(2):253-262. PubMed ID: 34554677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA-SMILR modulates RhoA/ROCK signaling by targeting miR-141 to regulate vascular remodeling in pulmonary arterial hypertension.
    Lei S; Peng F; Li ML; Duan WB; Peng CQ; Wu SJ
    Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H377-H391. PubMed ID: 32559140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NMDA-Type Glutamate Receptor Activation Promotes Vascular Remodeling and Pulmonary Arterial Hypertension.
    Dumas SJ; Bru-Mercier G; Courboulin A; Quatredeniers M; Rücker-Martin C; Antigny F; Nakhleh MK; Ranchoux B; Gouadon E; Vinhas MC; Vocelle M; Raymond N; Dorfmüller P; Fadel E; Perros F; Humbert M; Cohen-Kaminsky S
    Circulation; 2018 May; 137(22):2371-2389. PubMed ID: 29444988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FGF12 (Fibroblast Growth Factor 12) Inhibits Vascular Smooth Muscle Cell Remodeling in Pulmonary Arterial Hypertension.
    Yeo Y; Yi ES; Kim JM; Jo EK; Seo S; Kim RI; Kim KL; Sung JH; Park SG; Suh W
    Hypertension; 2020 Dec; 76(6):1778-1786. PubMed ID: 33100045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Grape seed procyanidin suppresses inflammation in cigarette smoke-exposed pulmonary arterial hypertension rats by the PPAR-γ/COX-2 pathway.
    Liu J; Hu S; Zhu B; Shao S; Yuan L
    Nutr Metab Cardiovasc Dis; 2020 Feb; 30(2):347-354. PubMed ID: 31791634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implication of EZH2 in the Pro-Proliferative and Apoptosis-Resistant Phenotype of Pulmonary Artery Smooth Muscle Cells in PAH: A Transcriptomic and Proteomic Approach.
    Habbout K; Omura J; Awada C; Bourgeois A; Grobs Y; Krishna V; Breuils-Bonnet S; Tremblay E; Mkannez G; Martineau S; Nadeau V; Roux-Dalvai F; Orcholski M; Jeyaseelan J; Gutstein D; Potus F; Provencher S; Bonnet S; Paulin R; Boucherat O
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33803922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of DP1 Aggravates Vascular Remodeling in Pulmonary Arterial Hypertension via mTORC1 Signaling.
    He Y; Zuo C; Jia D; Bai P; Kong D; Chen D; Liu G; Li J; Wang Y; Chen G; Yan S; Xiao B; Zhang J; Piao L; Li Y; Deng Y; Li B; Roux PP; Andreasson KI; Breyer RM; Su Y; Wang J; Lyu A; Shen Y; Yu Y
    Am J Respir Crit Care Med; 2020 May; 201(10):1263-1276. PubMed ID: 31917615
    [No Abstract]   [Full Text] [Related]  

  • 18. Nestin represents a potential marker of pulmonary vascular remodeling in pulmonary arterial hypertension associated with congenital heart disease.
    Zhou JJ; Li H; Qian YL; Quan RL; Chen XX; Li L; Li Y; Wang PH; Meng XM; Jing XL; He JG
    J Mol Cell Cardiol; 2020 Dec; 149():41-53. PubMed ID: 32950539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PFKFB3 in Smooth Muscle Promotes Vascular Remodeling in Pulmonary Arterial Hypertension.
    Kovacs L; Cao Y; Han W; Meadows L; Kovacs-Kasa A; Kondrikov D; Verin AD; Barman SA; Dong Z; Huo Y; Su Y
    Am J Respir Crit Care Med; 2019 Sep; 200(5):617-627. PubMed ID: 30817168
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasminogen activator Inhibitor-2 inhibits pulmonary arterial smooth muscle cell proliferation in pulmonary arterial hypertension via PI3K/Akt and ERK signaling.
    Zhang S; Wang J; Qi X; Tao X; Xie W; Wan J; Shen YH; Zhai Z
    Exp Cell Res; 2021 Jan; 398(1):112392. PubMed ID: 33227315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.